Take your tour through “SCIUS” and take advantage from our comprehensive source of scientific expert knowledge. Discover scientific publications, application notes, expert lectures, webinars, and many more valuable resources to support your big ideas and small daily routines alike.
Start your SCIUS search below.
Use the filter to search the knowledge source.
Antibody-based therapeutics are unique in that they are specific in terms of binding to their target antigen. Evaluation of cross-species and/or epitope reactivity of antibodies during the screening phase is of high importance.
This webinar overviews:
• The evaluation of cross species reactivity of antibodies in the primary screening phase using the IntelliCyt platform
• Applications of the IntelliCyt platform in different phases of the drug discovery process
Author: Dr. Markus Waldhuber
A Novel Multiplexed Screening Assay for Assessing Productivity of Antibody-Secreting Cell Lines: Simultaneous Measurement of Secreted Protein and Viable Cell Count
Scientists need powerful tools that can deliver results to fully understand the ability of candidate antibodies to interrupt cellular and molecular processes that lead to disease states.